{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:36:15Z","timestamp":1791290175653,"version":"4.3.0"},"reference-count":71,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T00:00:00Z","timestamp":1484265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>\u2003<\/jats:title>\n                    <jats:p>Hypophosphatasia (HPP) is caused by loss-of-function mutation(s) of the gene that encodes the tissue-nonspecific isoenzyme of alkaline phosphatase (TNSALP). Autosomal inheritance (dominant or recessive) from among more than 300 predominantly missense defects of TNSALP (ALPL) explains HPP's broad-ranging severity, the greatest of all skeletal diseases. In health, TNSALP is linked to cell surfaces and richly expressed in the skeleton and developing teeth. In HPP,TNSALP substrates accumulate extracellularly, including inorganic pyrophosphate (PPi), an inhibitor of mineralization. The PPi excess can cause tooth loss, rickets or osteomalacia, calcific arthropathies, and perhaps muscle weakness. Severely affected infants may seize from insufficient hydrolysis of pyridoxal 5\u02b9-phosphate (PLP), the major extracellular vitamin B6. Now, significant successes are documented for newborns, infants, and children severely affected by HPP given asfotase alfa, a hydroxyapatite-targeted recombinant TNSALP. Since fall 2015, this biologic is approved by regulatory agencies multinationally typically for pediatric-onset HPP. Safe and effective treatment is now possible for this last rickets to have a medical therapy, but a number of challenges involving diagnosis, understanding prognosis, and providing this treatment are reviewed herein. \u00a9 2017 American Society for Bone and Mineral Research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/jbmr.3075","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T13:48:55Z","timestamp":1484315335000},"page":"667-675","source":"Crossref","is-referenced-by-count":140,"title":["Hypophosphatasia: Enzyme Replacement Therapy Brings New Opportunities and New Challenges"],"prefix":"10.1093","volume":"32","author":[{"given":"Michael P","family":"Whyte","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Bone and Mineral DiseasesWashington University School of Medicine, and Center for Metabolic Bone Disease and Molecular Research, Shriners Hospital for ChildrenSt. LouisMOUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,1,13]]},"reference":[{"key":"2024021014203216300_jbmr3075-bib-0001","author":"Rosen","year":"2013"},{"key":"2024021014203216300_jbmr3075-bib-0002","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1001\/archpedi.1948.02030020840003","article-title":"Hypophosphatasia: a new developmental anomaly","volume":"75","author":"Rathbun","year":"1948","journal-title":"Am J Dis Child"},{"key":"2024021014203216300_jbmr3075-bib-0003","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.14","article-title":"Hypophosphatasia: aetiology, nosology, pathogenesis, diagnosis and treatment","volume":"12","author":"Whyte","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"2024021014203216300_jbmr3075-bib-0004","first-page":"337","author":"Whyte","year":"2013"},{"key":"2024021014203216300_jbmr3075-bib-0005","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJMoa1106173","article-title":"Enzyme replacement therapy in life-threatening hypophosphatasia","volume":"366","author":"Whyte","year":"2012","journal-title":"N Engl J Med"},{"issue":"e85971","key":"2024021014203216300_jbmr3075-bib-0006","first-page":"1","article-title":"Asfotase alfa therapy for children with hypophosphatasia","volume":"1","author":"Whyte","year":"2016","journal-title":"JCI Insight"},{"key":"2024021014203216300_jbmr3075-bib-0007","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1210\/jc.2015-3462","article-title":"Asfotase alfa treatment improves survival for perinatal and infantile hypophosphatasia","volume":"101","author":"Whyte","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024021014203216300_jbmr3075-bib-0008","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00223-015-0079-1","article-title":"Alkaline phosphatase and hypophosphatasia","volume":"98","author":"Millan","year":"2016","journal-title":"Calcif Tissue Int"},{"key":"2024021014203216300_jbmr3075-bib-0009","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(65)91422-4","article-title":"Excretion of inorganic pyrophosphate in hypophosphatasia","volume":"10","author":"Russell","year":"1965","journal-title":"Lancet"},{"key":"2024021014203216300_jbmr3075-bib-0010","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/212901a0","article-title":"Effect of pyrophosphate on hydroxyapatite and its implications in calcium homeostasis","volume":"212","author":"Fleisch","year":"1966","journal-title":"Nature"},{"key":"2024021014203216300_jbmr3075-bib-0011","first-page":"1555","article-title":"Matrix vesicles in osteomalacic hypophosphatasia bone contain apatite-like mineral crystals","volume":"151","author":"Anderson","year":"1997","journal-title":"Am J Pathol"},{"key":"2024021014203216300_jbmr3075-bib-0012","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.bone.2007.01.020","article-title":"Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T&gt;C, p.M226T; c.1112C&gt;T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene","volume":"40","author":"Baumgartner-Sigl","year":"2007","journal-title":"Bone"},{"key":"2024021014203216300_jbmr3075-bib-0013","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/jbmr.2110","article-title":"Calcific periarthritis as the only clinical manifestation of hypophosphatasia in middle-aged sisters","volume":"29","author":"Guanabens","year":"2014","journal-title":"J Bone Miner Res"},{"key":"2024021014203216300_jbmr3075-bib-0014","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bone.2015.02.022","article-title":"Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients","volume":"75","author":"Whyte","year":"2015","journal-title":"Bone"},{"key":"2024021014203216300_jbmr3075-bib-0015","author":"Mornet","year":"2015"},{"key":"2024021014203216300_jbmr3075-bib-0016","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/0002-9343(57)90124-9","article-title":"Hypophosphatasia","volume":"22","author":"Fraser","year":"1957","journal-title":"Am J Med"},{"key":"2024021014203216300_jbmr3075-bib-0017","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1469-1809.2011.00642.x","article-title":"A molecular-based estimation of the prevalence of hypophosphatasia in the European population","volume":"75","author":"Mornet","year":"2011","journal-title":"Ann Hum Genet"},{"key":"2024021014203216300_jbmr3075-bib-0018","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1006\/geno.1993.1305","article-title":"A homoallelic Gly317\u2192Asp mutation in ALPL causes the perinatal (lethal) form of hypophosphatasia in Canadian mennonites","volume":"17","author":"Greenberg","year":"1993","journal-title":"Genomics"},{"key":"2024021014203216300_jbmr3075-bib-0019","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/jhg.2011.6","article-title":"Hypophosphatasia now draws more attention of both clinicians and researchers: a commentary on prevelance of c. 1559delT in ALPL, a common mutation resulting in the perinatal (lethal) form of hypophosphatasias in Japanese and effects of the mutation on heterozygous carriers","volume":"56","author":"Ozono","year":"2011","journal-title":"J Hum Genet"},{"key":"2024021014203216300_jbmr3075-bib-0020","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jpeds.2006.01.031","article-title":"Homozygosity for TNSALP mutation 1348C&gt;T (Arg 433Cys) causes infantile hypophosphatasia manifesting transient disease correction and variably lethal outcome in a kindred of black ancestry","volume":"148","author":"Whyte","year":"2006","journal-title":"J Pediatr"},{"key":"2024021014203216300_jbmr3075-bib-0021","first-page":"S115","article-title":"Hypophosphatasia: the c.1133A&gt;T, p.D378V transversion is the most common American TNSALP mutation [abstract]","volume":"21","author":"Mumm","year":"2006","journal-title":"J Bone Miner Res"},{"key":"2024021014203216300_jbmr3075-bib-0022","author":"Wenkert"},{"key":"2024021014203216300_jbmr3075-bib-0023","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1002\/jbmr.454","article-title":"Hypophosphatasia: non-lethal disease despite skeletal presentation in utero (17 new cases and literature review)","volume":"26","author":"Wenkert","year":"2011","journal-title":"J Bone Miner Res"},{"key":"2024021014203216300_jbmr3075-bib-0024","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bone.2015.02.022","article-title":"Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients","volume":"75","author":"Whyte","year":"2015","journal-title":"Bone"},{"key":"2024021014203216300_jbmr3075-bib-0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bone.2016.08.019","article-title":"Hypophosphatasia: natural history study of 101 affected children studied at a single research center","volume":"93","author":"Whyte","year":"2016","journal-title":"Bone"},{"key":"2024021014203216300_jbmr3075-bib-0026","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00005792-197909000-00001","article-title":"Adult hypophosphatasia. Clinical, laboratory, and genetic investigation of a large kindred with review of the literature","volume":"58","author":"Whyte","year":"1979","journal-title":"Medicine (Baltimore)"},{"key":"2024021014203216300_jbmr3075-bib-0027","doi-asserted-by":"crossref","first-page":"676","DOI":"10.4158\/EP.12.6.676","article-title":"Low serum alkaline phosphatase activity and pathologic fracture: case report and brief review of hypophosphatasia diagnosed in adulthood","volume":"12","author":"Khandwala","year":"2006","journal-title":"Endocr Pract"},{"key":"2024021014203216300_jbmr3075-bib-0028","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/jbmr.1565","article-title":"Atypical femoral fractures\u201d during bisphosphonate exposure in adult hypophosphatasia","volume":"27","author":"Sutton","year":"2012","journal-title":"J Bone Miner Res"},{"key":"2024021014203216300_jbmr3075-bib-0029","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2106\/00004623-198668070-00004","article-title":"Management of femoral fractures and pseudofractures in adult hypophosphatasia","volume":"68","author":"Coe","year":"1986","journal-title":"J Bone Joint Surg (Am)"},{"key":"2024021014203216300_jbmr3075-bib-0030","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1359\/jbmr.081253","article-title":"Atypical femoral fractures, bisphosphonates, and adult hypophosphatasia","volume":"24","author":"Whyte","year":"2009","journal-title":"J Bone Miner Res"},{"key":"2024021014203216300_jbmr3075-bib-0031","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/ard.48.7.571","article-title":"Crystal deposition in hypophosphatasia: a reappraisal","volume":"48","author":"Chuck","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"2024021014203216300_jbmr3075-bib-0032","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0002-9343(82)90474-0","article-title":"Adult hypophosphatasia with chondrocalcinosis and arthropathy. Variable penetrance of hypophosphatasemia in a large Oklahoma kindred","volume":"72","author":"Whyte","year":"1982","journal-title":"Am J Med"},{"key":"2024021014203216300_jbmr3075-bib-0033","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1001\/archinte.1981.00340130158037","article-title":"Fifty-year follow-up of hypophosphatasia","volume":"141","author":"Weinstein","year":"1981","journal-title":"Arch Int Med"},{"key":"2024021014203216300_jbmr3075-bib-0034","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/adc.65.1.130","article-title":"Myopathy with hypophosphatasia","volume":"65","author":"Seshia","year":"1990","journal-title":"Arch Dis Child"},{"key":"2024021014203216300_jbmr3075-bib-0035","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0022-3476(82)80061-9","article-title":"Infantile hypophosphatasia: enzyme replacement therapy by intravenous infusion of alkaline phosphatase-rich plasma from patients with Paget bone disease","volume":"101","author":"Whyte","year":"1982","journal-title":"J Pediatr"},{"key":"2024021014203216300_jbmr3075-bib-0036","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/8904_2013_224","article-title":"Outcome of perinatal hypophosphatasia in Manitoba Mennonites: a retrospective cohort analysis","volume":"11","author":"Leung","year":"2013","journal-title":"JIMD Rep"},{"key":"2024021014203216300_jbmr3075-bib-0037","first-page":"559","article-title":"L'hypophosphatasie affection polymorphe de fr\u00e9quence peut-\u011btre sous estim\u00e9e [French]","volume":"91","author":"Taillard","year":"1984","journal-title":"La M\u00e9decine Infantile"},{"key":"2024021014203216300_jbmr3075-bib-0038","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3109\/15513818809022304","article-title":"Pulmonary hypoplasia in neonatal hypophosphatasia","volume":"8","author":"Silver","year":"1988","journal-title":"Pediatr Pathol"},{"key":"2024021014203216300_jbmr3075-bib-0039","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0140-6736(55)91704-9","article-title":"The excretion of phosphoethanolamine and hypophosphatasia","volume":"268","author":"McCance","year":"1955","journal-title":"Lancet"},{"key":"2024021014203216300_jbmr3075-bib-0040","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1172\/JCI112031","article-title":"Markedly increased circulating pyridoxal-5\u2032-phosphate levels in hypophosphatasia. Alkaline phosphatase acts in vitamin B6 metabolism","volume":"76","author":"Whyte","year":"1985","journal-title":"J Clin Invest"},{"key":"2024021014203216300_jbmr3075-bib-0041","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1210\/jcem-55-1-178","article-title":"Circulating vitamin D metabolite levels in hypophosphatasia","volume":"55","author":"Whyte","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"2024021014203216300_jbmr3075-bib-0042","first-page":"1606","article-title":"Alkaline phosphatase dissolves calcium pyrophosphate dihydrate crystals","volume":"18","author":"Xu","year":"1991","journal-title":"J Rheumatol"},{"key":"2024021014203216300_jbmr3075-bib-0043","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/10408369109106862","article-title":"Hypophosphatasia and the extracellular metabolism of inorganic pyrophosphate: clinical and laboratory aspects","volume":"28","author":"Caswell","year":"1991","journal-title":"Crit Rev Clin Lab Sci"},{"key":"2024021014203216300_jbmr3075-bib-0044","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1210\/jc.2006-1902","article-title":"Adult hypophosphatasia treated with teriparatide","volume":"92","author":"Whyte","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"2024021014203216300_jbmr3075-bib-0045","first-page":"399","article-title":"Hyperphosphatemia due to enhanced renal reclamation of phosphate in hypophosphatasia [abstract]","volume":"2","author":"Whyte","year":"1987","journal-title":"J Bone Miner Res"},{"key":"2024021014203216300_jbmr3075-bib-0046","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/jbmr.1752","article-title":"Severe skeletal toxicity from protracted etidronate therapy for generalized arterial calcification of infancy","volume":"28","author":"Otero","year":"2013","journal-title":"J Bone Miner Res"},{"key":"2024021014203216300_jbmr3075-bib-0047","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/CIRCGENETICS.108.797704","article-title":"Hypophosphatemia, hyperphosphaturia, and bisphosphonate treatment are associated with survival beyond infancy in generalized arterial calcification of infancy","volume":"1","author":"Rutsch","year":"2008","journal-title":"Circ Cardiovasc Genet"},{"key":"2024021014203216300_jbmr3075-bib-0048","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0022-3476(84)80079-7","article-title":"Enzyme replacement therapy for infantile hypophosphatasia attempted by intravenous infusions of alkaline phosphatase-rich Paget plasma: results in three additional patients","volume":"105","author":"Whyte","year":"1984","journal-title":"J Pediatr"},{"key":"2024021014203216300_jbmr3075-bib-0049","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00005792-198401000-00002","article-title":"Hypophosphatasia: clinicopathologic comparison of the infantile, childhood, and adult forms","volume":"63","author":"Fallon","year":"1984","journal-title":"Medicine (Baltimore)"},{"key":"2024021014203216300_jbmr3075-bib-0050","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/jbmr.2178","article-title":"Clinical and radiographic findings in adults with persistent hypophosphatasemia","volume":"29","author":"McKiernan","year":"2014","journal-title":"J Bone Miner Res"},{"key":"2024021014203216300_jbmr3075-bib-0051","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/BF00442478","article-title":"Lethal osteogenesis imperfecta: abnormal collagen metabolism and biochemical characteristics of hypophosphatasia","volume":"147","author":"Royce","year":"1988","journal-title":"Eur J Ped"},{"key":"2024021014203216300_jbmr3075-bib-0052","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/ajmg.a.33146","article-title":"Severe cleidocranial dysplasia and hypophosphatasia in a child with microdeletion of the C-terminal region of RUNX2","volume":"152A","author":"El-Gharbawy","year":"2010","journal-title":"Am J Med Genet A"},{"key":"2024021014203216300_jbmr3075-bib-0053","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/BF01800216","article-title":"Increased plasma pyridoxal-5\u2032-phosphate levels before and after pyridoxine loading in carriers of perinatal\/infantile hypophosphatasia","volume":"13","author":"Chodirker","year":"1990","journal-title":"J Inherit Metab Dis"},{"key":"2024021014203216300_jbmr3075-bib-0054","first-page":"1","article-title":"Phosphorylethanolamine and hypophosphatasia","volume":"15","author":"Rasmussen","year":"1968","journal-title":"Dan Med Bulletin"},{"key":"2024021014203216300_jbmr3075-bib-0055","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0002-9343(78)90189-4","article-title":"The urinary excretion of phosphoethanolamine in diseases other than hypophosphatasia","volume":"64","author":"Licata","year":"1978","journal-title":"Am J Med"},{"key":"2024021014203216300_jbmr3075-bib-0056","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1359\/jbmr.090308","article-title":"Chronic recurrent multifocal osteomyelitis mimicked in childhood hypophosphatasia","volume":"24","author":"Whyte","year":"2009","journal-title":"J Bone Miner Res"},{"key":"2024021014203216300_jbmr3075-bib-0057","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jocd.2012.01.004","article-title":"Improving dual-energy X-ray absorptiometry (DXA) interpretation: a simple equation for height correction for pre-teenage children","volume":"15","author":"Zhang","year":"2012","journal-title":"J Clin Densitom"},{"key":"2024021014203216300_jbmr3075-bib-0058","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bone.2013.12.009","article-title":"Perinatal hypophosphatasia caused by uniparental isodisomy","volume":"60","author":"Watanabe","year":"2014","journal-title":"Bone"},{"key":"2024021014203216300_jbmr3075-bib-0059","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/pd.1970151104","article-title":"Infantile hypophosphatasia: successful prenatal assessment by testing for tissue-non-specific alkaline phosphatase isoenzyme gene mutations","volume":"15","author":"Henthorn","year":"1995","journal-title":"Prenat Diagn"},{"key":"2024021014203216300_jbmr3075-bib-0060","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/ppul.22527","article-title":"Respiratory mechanics in an infant with perinatal lethal hypophosphatasia treated with human recombinant enzyme replacement therapy","volume":"47","author":"Rodriguez","year":"2012","journal-title":"Pediatr Pulmonol"},{"key":"2024021014203216300_jbmr3075-bib-0061","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ymgme.2016.06.010","article-title":"Physical therapy management of infants and children with hypophosphatasia","volume":"119","author":"Phillips","year":"2016","journal-title":"Mol Genet Metab"},{"key":"2024021014203216300_jbmr3075-bib-0062","first-page":"S155","article-title":"Failure of hyperphosphatasemia by intravenous infusion of purified placental alkaline phosphatase (ALP) to correct severe hypophosphatasia: evidence against a role for circulating ALP in skeletal mineralization [abstract]","volume":"7","author":"Whyte","year":"1992","journal-title":"J Bone Miner Res"},{"key":"2024021014203216300_jbmr3075-bib-0063","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1359\/jbmr.2003.18.4.624","article-title":"Marrow cell transplantation for infantile hypophosphatasia","volume":"18","author":"Whyte","year":"2003","journal-title":"J Bone Miner Res"},{"key":"2024021014203216300_jbmr3075-bib-0064","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1210\/jc.2006-2131","article-title":"Infantile hypophosphatasia: trial of transplantation therapy using bone fragments and cultured osteoblasts","volume":"92","author":"Cahill","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2024021014203216300_jbmr3075-bib-0065","doi-asserted-by":"crossref","first-page":"941","DOI":"10.4158\/EP15890.OR","article-title":"Adult hypophosphatasia treated with teriparatide: report of two patients and review of the literature","volume":"22","author":"Camacho","year":"2016","journal-title":"Endocr Pract"},{"key":"2024021014203216300_jbmr3075-bib-0066","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1359\/jbmr.071213","article-title":"Enzyme replacement therapy for murine hypophosphatasia","volume":"23","author":"Mill\u00e1n","year":"2008","journal-title":"J Bone Miner Res"},{"key":"2024021014203216300_jbmr3075-bib-0067","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1359\/jbmr.1999.14.12.2015","article-title":"Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia","volume":"14","author":"Fedde","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2024021014203216300_jbmr3075-bib-0068","author":"Liese","year":"2016"},{"issue":"Suppl 1","key":"2024021014203216300_jbmr3075-bib-0069","first-page":"S108","article-title":"Ambulatory performance in adolescents and adults with hypophosphatasia treated wtih Asfotase alfa: data from a phase II, randomized, dose-ranging open-label, multi-center study [Abstract]","author":"Kishnani","year":"2016","journal-title":"J Bone Miner Res"},{"key":"2024021014203216300_jbmr3075-bib-0070","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00431-015-2641-2","article-title":"Lethal hypophosphatasia successfully treated with enzyme replacement from day 1 after birth","volume":"175","author":"Okazaki","year":"2016","journal-title":"Eur J Pediatr"},{"key":"2024021014203216300_jbmr3075-bib-0071","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/jbmr.2420","article-title":"Pathophysiological role of vascular smooth muscle alkaline phosphatase in medial artery calcification","volume":"30","author":"Sheen","year":"2015","journal-title":"J Bone Miner Res"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.3075","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/32\/4\/667\/56652307\/jbmr3075.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/32\/4\/667\/56652307\/jbmr3075.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T10:58:27Z","timestamp":1710327507000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/32\/4\/667-675\/7605570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,13]]},"references-count":71,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,1,13]]},"published-print":{"date-parts":[[2017,4,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.3075","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727203530.793532426","asserted-by":"object"}]},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,4,1]]},"published":{"date-parts":[[2017,1,13]]}}}